These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2. Thaingtamtanha T; Baeurle SA J Mol Model; 2022 Jul; 28(8):224. PubMed ID: 35854129 [TBL] [Abstract][Full Text] [Related]
23. Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity. Kuzmina A; Korovin D; Cohen Lass I; Atari N; Ottolenghi A; Hu P; Mandelboim M; Rosental B; Rosenberg E; Diaz-Griffero F; Taube R Heliyon; 2023 Jun; 9(6):e16750. PubMed ID: 37292300 [TBL] [Abstract][Full Text] [Related]
24. Furin cleavage of the SARS-CoV-2 spike is modulated by Zhang L; Mann M; Syed ZA; Reynolds HM; Tian E; Samara NL; Zeldin DC; Tabak LA; Ten Hagen KG Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34732583 [TBL] [Abstract][Full Text] [Related]
26. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication. Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378 [TBL] [Abstract][Full Text] [Related]
27. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. Rajah MM; Bernier A; Buchrieser J; Schwartz O J Mol Biol; 2022 Mar; 434(6):167280. PubMed ID: 34606831 [TBL] [Abstract][Full Text] [Related]
28. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles. Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269 [TBL] [Abstract][Full Text] [Related]
29. Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor. Wang J; Luo J; Wen Z; Wang X; Shuai L; Zhong G; Wang C; Sun Z; Chen W; Ge J; Liu R; Wang X; Bu Z mBio; 2022 Feb; 13(1):e0244321. PubMed ID: 35012335 [TBL] [Abstract][Full Text] [Related]
30. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Belouzard S; Chu VC; Whittaker GR Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428 [TBL] [Abstract][Full Text] [Related]
31. A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: Effects on proteolytic cleavage and ACE2 binding. Spelios MG; Capanelli JM; Li AW Immunol Lett; 2022 Feb; 242():1-7. PubMed ID: 35007661 [TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707 [TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Yamamoto Y; Inoue T; Inoue M; Murae M; Fukasawa M; Kaneko MK; Kato Y; Noguchi K Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555473 [TBL] [Abstract][Full Text] [Related]
34. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
35. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease. Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162 [TBL] [Abstract][Full Text] [Related]
36. Rapid quantitative monitoring of SARS-CoV-2 spike protein-mediated syncytia formation using split NanoLuc. Wang H; Guo S; Yang H J Med Virol; 2022 Dec; 94(12):6073-6077. PubMed ID: 35940856 [TBL] [Abstract][Full Text] [Related]
37. Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2. Yu S; Zheng X; Zhou Y; Gao Y; Zhou B; Zhao Y; Li T; Li Y; Mou J; Cui X; Yang Y; Li D; Chen M; Lavillette D; Meng G PLoS Pathog; 2023 Nov; 19(11):e1011789. PubMed ID: 37948454 [TBL] [Abstract][Full Text] [Related]
38. Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection. Wang Z; Zhong K; Wang G; Lu Q; Li H; Wu Z; Zhang Z; Yang N; Zheng M; Wang Y; Nie C; Zhou L; Tong A Gene; 2023 Mar; 856():147144. PubMed ID: 36577450 [TBL] [Abstract][Full Text] [Related]
39. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586 [TBL] [Abstract][Full Text] [Related]
40. Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection. Lin JJ; Tien CF; Kuo YP; Lin EJ; Tsai WH; Chen MY; Tsai PJ; Su YW; Pathak N; Yang JM; Yu CY; Chuang ZS; Wu HC; Tsai WT; Dai SS; Liao HC; Chai KM; Su YS; Chuang TH; Liu SJ; Chen HW; Dou HY; Chen FJ; Chen CT; Liao CL; Yu GY Front Immunol; 2022; 13():872047. PubMed ID: 35585971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]